Extensive Genetic Diversity and Epidemiological Patterns of Factor H-Binding Protein Variants among Neisseria

Zhizhou Tan1, Juan Xu1, Jie Che1

  • 1National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.

Microorganisms
|March 28, 2024
PubMed

Insights

Factor H-binding protein (fHbp) variants in Chinese Neisseria meningitidis were analyzed. Four specific fHbp variants show persistent prevalence, indicating potential for broad-spectrum serogroup B vaccines.

Area of Science:

  • Microbiology and Immunology
  • Vaccine Development
  • Epidemiology

Background:

  • Factor H-binding protein (fHbp) is a key virulence factor of Neisseria meningitidis, crucial for developing vaccines against serogroup B invasive meningococcal disease (IMD).
  • Understanding the genetic diversity and epidemiology of fHbp variants is essential for effective vaccine strategies.
  • China presents a unique epidemiological landscape for Neisseria meningitidis.

Purpose of the Study:

  • To comprehensively investigate the genetic diversity and epidemiological patterns of fHbp variants in Chinese Neisseria meningitidis isolates.
  • To identify prevalent fHbp variants suitable for nationwide vaccine development against serogroup B IMD.
  • To establish a basis for ongoing surveillance of meningococcal strains.

Main Methods:

  • Analysis of the NEIS0349 locus encompassing complete fHbp coding sequences in 1013 Chinese N. meningitidis isolates.
  • Identification and characterization of 109 distinct fHbp allelic variants.
  • Phylogenetic reconstruction and epidemiological analysis, including temporal and geographical distribution.

Main Results:

  • A total of 109 fHbp variants were identified among 1013 Chinese N. meningitidis isolates.
  • Four fHbp variants (v2.16, v2.18, v2.404, and v2.21) demonstrated persistent nationwide prevalence from 2011-2021.
  • These prevalent variants were found in both patient and healthy carrier serogroup B strains.

Conclusions:

  • Specific fHbp variants exhibit consistent nationwide prevalence in China, highlighting their importance in the local epidemiology of IMD.
  • The identified prevalent fHbp variants are promising candidates for inclusion in next-generation vaccines targeting serogroup B Neisseria meningitidis.
  • Continuous surveillance of fHbp genetic diversity is critical for informing and adapting vaccine development strategies against invasive meningococcal disease.